Stents linked to low major adverse coronary events
Wednesday, October 30, 2013 - 14:30
in Health & Medicine
A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible polymer stents in patients undergoing percutaneous coronary intervention.